For the quarter ended March 2025, Techne (TECH) reported revenue of $316.18 million, up 4.2% over the same period last year. EPS came in at $0.56, compared to $0.48 in the year-ago quarter.The reported revenue represents a surprise of +0.30% over the Zacks Consensus Estimate of $315.24 million. With the consensus EPS estimate being $0.51, the EPS surprise was +9.80%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expecta ...

Bio-Techne (TECH) Q3 2025 Earnings Call May 07, 2025 09:00 AM ET Company Participants David Clair - Investor RelationsKim Kelderman - CEO, President & DirectorJim Hippel - EVP & CFOPuneet Souda - Senior MDDaniel Markowitz - Vice PresidentDan Arias - Managing DirectorThomas DeBourcy - PrincipalPatrick Donnelly - Managing Director Conference Call Participants Dan Leonard - Managing Director & Research AnalystMatt Larew - Research Analyst - HealthcareSung Ji Nam - Managing Director, Senior Equity Research Anal ...

Bio-Techne (TECH) Q3 2025 Earnings Call May 07, 2025 09:00 AM ET Speaker0 Good morning, and welcome to Bio Techne Earnings Conference Call for the Third Quarter of Fiscal Year twenty twenty five. At this time, all participants have been placed in listen only mode, and the call will be opened for questions following the management's prepared remarks. During our Q and A session, please limit yourself to one question and a follow-up. I would now like to turn the call over to David Claire, Bio Vice President, I ...

Investors in Bio-Techne Corporation (TECH) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 18, 2025 $80 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could ...

Techne (TECH) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.48 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of 9.80%. A quarter ago, it was expected that this maker of medical testing and diagnostic products would post earnings of $0.38 per share when it actually produced earnings of $0.42, delivering a surprise of 10.53%. There a ...

Exhibit 99.1 BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS Minneapolis/May 7, 2025/ Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2025. Third Quarter FY2025 Highlights The Company's financial statements are prepared in accordance with accounting principles generally accepted in the United States (GAAP). Adjusted diluted EPS, adjusted net earnings, adjusted gross margin, adjusted operating income, adjusted tax rate, organic revenue, ...

Summary⚈ Congresswoman April McClain Delaney bought Bio-Techne stock twice in April 2025.⚈ The stock has dropped nearly 30% year-to-date and remains unprofitable post-purchase.⚈ Delaney’s committee roles suggest potential informational advantages in biotech-related decisions.Finbold’s congressional trading radar has recently picked up a suspicious stock bet made by Maryland congresswoman April McClain Delaney involving a low-profile biotech stock. The representative purchased Bio-Techne Corp stock (NASDAQ: ...

SCOTTSDALE, Ariz., April 30, 2025 /PRNewswire/ -- Cyber Enviro-Tech, Inc. (OTCQB: CETI) announced today that it is conducting critical testing of its advanced water purification technology for the oil and gas industry. If successful, the results could lead to contracts potentially valued at over $100 million annually, as referenced in the Company's April 17, 2025 press release.Produced water — a byproduct of oil and gas extraction — typically contains high concentrations of salts, hydrocarbons, heavy metals ...

Bio-Techne Corporation (TECH) is set to release third-quarter fiscal 2025 results on May 7, before the opening bell.The life science and diagnostic product maker posted adjusted earnings per share (EPS) of 42 cents in the last reported quarter, which exceeded the Zacks Consensus Estimate by 10.5%. The company beat on earnings in three of the trailing four quarters and missed in one, the average surprise being 5.37%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar).Q3 Estimates for TE ...

文章核心观点 Bio - Techne公司宣布其最新空间生物学进展——蛋白质邻近原位检测新检测方法的早期访问计划，该方法基于RNAscope™技术，能揭示完整组织内蛋白质间功能相互作用，解决传统方法的不足 [1][2] 公司进展 - 公司宣布蛋白质邻近原位检测新检测方法的早期访问计划，该方法基于Advanced Cell Diagnostics RNAscope™技术，可揭示完整组织内蛋白质间功能相互作用，提供探索分子信号如何影响疾病进程的空间解决方案 [1] - 新检测方法能解决传统研究组织分子相互作用方法的不足，以亚细胞分辨率提供清晰视觉信号，与RNAscope™ Multiomic LS工作流程兼容，对评估免疫检查点动力学等研究领域有重要价值 [2] 项目安排 - 早期访问计划面向有兴趣将空间蛋白质邻近功能纳入工作流程的选定机构和研究人员 [3] - 公司科学团队将在2025年美国癌症研究协会（AACR）年会上分享概念验证数据和案例研究 [3] 公司概况 - Bio - Techne是全球生命科学公司，为研究和临床诊断界提供创新工具和生物活性试剂，产品助力生物过程研究、疾病诊断和药物发现 [4] - 公司产品组合有数十万种产品，2024财年净销售额约12亿美元，全球约有3100名员工 [4] 公司联系方式 - 联系人是投资者关系与企业发展副总裁David Clair，邮箱[email protected]，电话612 - 656 - 4416 [5]